Image 1 of 1
mpiDPA_020118_Stock_469.jpg
A lab workers produces tube sets for biotech company Miltenyi Biotecc in Teterow, Germany, 1 February 2018. A new joint project has started with its help: The biotech company wants to develop vaccines against tumours together with the University of Rostock and Greifswald. The vaccines are meant to cause an immune reaction against cancer. The project gained 6.4 million euros state support over a period of six years. Photo: Bernd Wüstneck/dpa /MediaPunch ***FOR USA ONLY***

***FOR USA ONLY***